Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-124559
Filing Date
2022-12-05
Accepted
2022-12-05 16:05:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2231804d1_424b5.htm 424B5 393877
2 GRAPHIC tm2231804d1_424b5img001.jpg GRAPHIC 6975
3 GRAPHIC tm2231804d1_424b5img002.jpg GRAPHIC 9580
4 GRAPHIC tm2231804d1_424b5img004.jpg GRAPHIC 2303
  Complete submission text file 0001104659-22-124559.txt   416270
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255726 | Film No.: 221444966
SIC: 2834 Pharmaceutical Preparations